These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 19594492)

  • 1. Markers aiding the diagnosis of chondroid tumors: an immunohistochemical study including osteonectin, bcl-2, cox-2, actin, calponin, D2-40 (podoplanin), mdm-2, CD117 (c-kit), and YKL-40.
    Daugaard S; Christensen LH; Høgdall E
    APMIS; 2009 Jul; 117(7):518-25. PubMed ID: 19594492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinguishing chordoid meningiomas from their histologic mimics: an immunohistochemical evaluation.
    Sangoi AR; Dulai MS; Beck AH; Brat DJ; Vogel H
    Am J Surg Pathol; 2009 May; 33(5):669-81. PubMed ID: 19194275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. D2-40 functions as an effective chondroid marker distinguishing true chondroid tumors from chordoma.
    Huse JT; Pasha TL; Zhang PJ
    Acta Neuropathol; 2007 Jan; 113(1):87-94. PubMed ID: 17021752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical comparison of chordoma with chondrosarcoma, myxopapillary ependymoma, and chordoid meningioma.
    Cho HY; Lee M; Takei H; Dancer J; Ro JY; Zhai QJ
    Appl Immunohistochem Mol Morphol; 2009 Mar; 17(2):131-8. PubMed ID: 19521276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of tau proteins and tubulin in extraskeletal myxoid chondrosarcoma, chordoma, and other chondroid tumors.
    Hu B; McPhaul L; Cornford M; Gaal K; Mirra J; French SW
    Am J Clin Pathol; 1999 Aug; 112(2):189-93. PubMed ID: 10439798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Keratin subsets and monoclonal antibody HBME-1 in chordoma: immunohistochemical differential diagnosis between tumors simulating chordoma.
    O'Hara BJ; Paetau A; Miettinen M
    Hum Pathol; 1998 Feb; 29(2):119-26. PubMed ID: 9490269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chondroid chordomas and low-grade chondrosarcomas of the craniospinal axis. An immunohistochemical analysis of 17 cases.
    Wojno KJ; Hruban RH; Garin-Chesa P; Huvos AG
    Am J Surg Pathol; 1992 Dec; 16(12):1144-52. PubMed ID: 1463093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brachyury, SOX-9, and podoplanin, new markers in the skull base chordoma vs chondrosarcoma differential: a tissue microarray-based comparative analysis.
    Oakley GJ; Fuhrer K; Seethala RR
    Mod Pathol; 2008 Dec; 21(12):1461-9. PubMed ID: 18820665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Type II collagen, but not aggrecan expression, distinguishes clear cell chondrosarcoma and chondroblastoma.
    Söder S; Oliveira AM; Inwards CY; Müller S; Aigner T
    Pathology; 2006 Feb; 38(1):35-8. PubMed ID: 16484006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parachordoma is immunohistochemically and cytogenetically distinct from axial chordoma and extraskeletal myxoid chondrosarcoma.
    Folpe AL; Agoff SN; Willis J; Weiss SW
    Am J Surg Pathol; 1999 Sep; 23(9):1059-67. PubMed ID: 10478665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential diagnosis of chordoma, chondroid, and ependymal tumors as aided by anti-intermediate filament antibodies.
    Miettinen M; Lehto VP; Dahl D; Virtanen I
    Am J Pathol; 1983 Aug; 112(2):160-9. PubMed ID: 6192722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chondroid chordoma--a variant of chordoma. A morphologic and immunohistochemical study.
    Rosenberg AE; Brown GA; Bhan AK; Lee JM
    Am J Clin Pathol; 1994 Jan; 101(1):36-41. PubMed ID: 7506477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovered on gastrointestinal stromal tumour 1 (DOG1): a useful immunohistochemical marker for diagnosing chondroblastoma.
    Akpalo H; Lange C; Zustin J
    Histopathology; 2012 Jun; 60(7):1099-106. PubMed ID: 22335248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of radiological features relative to histopathology in 42 skull-base chordomas and chondrosarcomas.
    Pamir MN; Ozduman K
    Eur J Radiol; 2006 Jun; 58(3):461-70. PubMed ID: 16631334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. S-100 protein immunostaining in the differential diagnosis of chondroblastoma.
    Monda L; Wick MR
    Hum Pathol; 1985 Mar; 16(3):287-93. PubMed ID: 2579018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of osteonectin for differential diagnosis of osteogenic bone tumors: an immunohistochemical and in situ hybridization approach.
    Park YK; Yang MH; Park HR
    Skeletal Radiol; 1996 Jan; 25(1):13-7. PubMed ID: 8717113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunohistochemical differentiation of leiomyocellular tumors and tumors with myogenic differentiation].
    Povýsil C; Ciprová V; Dundr P; Horáková M
    Cesk Patol; 2003 Apr; 39(2):64-8. PubMed ID: 12874903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of c-met proto-oncogene product (c-MET) in benign and malignant bone tumors.
    Naka T; Iwamoto Y; Shinohara N; Ushijima M; Chuman H; Tsuneyoshi M
    Mod Pathol; 1997 Aug; 10(8):832-8. PubMed ID: 9267827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical investigation of chordomas: histogenetic and differential diagnostic aspects.
    Bouropoulou V; Bosse A; Roessner A; Vollmer E; Edel G; Wuisman P; Härle A
    Curr Top Pathol; 1989; 80():183-203. PubMed ID: 2776494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The H3F3 K36M mutant antibody is a sensitive and specific marker for the diagnosis of chondroblastoma.
    Amary MF; Berisha F; Mozela R; Gibbons R; Guttridge A; O'Donnell P; Baumhoer D; Tirabosco R; Flanagan AM
    Histopathology; 2016 Jul; 69(1):121-7. PubMed ID: 26844533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.